| (Values in U.S. Thousands) | Dec, 2015 | Dec, 2014 | Dec, 2013 | Dec, 2012 | Dec, 2011 |
| Sales | 128,280 | 151,570 | 162,430 | 89,700 | 55,910 |
| Sales Growth | -15.37% | -6.69% | +81.08% | +60.44% | +17.80% |
| Net Income | -16,330 | 1,010 | -107,410 | -117,030 | -74,160 |
| Net Income Growth | -1,716.83% | +100.94% | +8.22% | -57.81% | +38.63% |
Sequenom Inc (SQNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Sequenom Inc. is in the field of industrial genomics. Industrial genomics is the large scale commercial use of the knowledge of DNA variations for improving health, agriculture and livestock. These variations are the differences between individuals, including disease predispositions and variations in drug responses. Single nucleotide polymorphisms are the most common variations. The company has developed the MassArray system, an accurate, cost-effective technology that is capable of high throughput single nucleotide polymorphism analysis at high speeds.
Fiscal Year End Date: 12/31